Changes in the intestinal microbiota following the administration of azithromycin in a randomised placebo-controlled trial among infants in south India

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Parker, Edward P K ^a   Praharaj, Ira ^b   John, Jacob ^b   Kaliappan, Saravanakumar Puthupalayam ^b   Kampmann, Beate ^a,c   Kang, Gagandeep ^b   Grassly, Nicholas C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CHRISTIAN MEDICAL COLLEGE   (India)

^c Disease Control and Elimination   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN;

AGE; BACTERIAL INFECTION; BACTERIUM; BIODIVERSITY; CLASSIFICATION; CONTROLLED STUDY; DRUG EFFECT; EPIDEMIOLOGY; FEMALE; GASTROENTERITIS; GENETICS; HEALTH SURVEY; HUMAN; INDIA; INFANT; INTESTINE FLORA; MALE; METAGENOME; METAGENOMICS; MICROBIOLOGY; NEWBORN; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TIME FACTOR;

AGE FACTORS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTERIA; BACTERIAL INFECTIONS; BIODIVERSITY; FEMALE; GASTROENTERITIS; GASTROINTESTINAL MICROBIOME; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MALE; METAGENOME; METAGENOMICS; PUBLIC HEALTH SURVEILLANCE; TIME FACTORS;

EID: 85027997549     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-06862-0     Document Type: Article

References (33)

1. Azad, M. B., Bridgman, S. L., Becker, A. B. & Kozyrskyj, A. L. Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int. J. Obes. 38, 1290-1298 (2014).
2. Arrieta, M. C. et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci. Trans. Med. 7, 307ra152 (2015).
3. Blaser, M. J. Antibiotic use and its consequences for the normal microbiome. Science 352, 544-545 (2016).
4. Nobel, Y. R. et al. Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment. Nat. Commun. 6, 7486 (2015).
5. Van Boeckel, T. P. et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect. Dis. 14, 742-750 (2014).
6. Korpela, K. et al. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat. Commun. 7, 10410 (2016).
7. Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222-227 (2012).
8. Grassly, N. C. et al. The effect of azithromycin on the immunogenicity of oral poliovirus vaccine: a double-blind randomised placebo-controlled trial in seronegative Indian infants. Lancet Infect. Dis. 16, 905-914 (2016).
9. Nelson, M. C., Morrison, H. G., Benjamino, J., Grim, S. L. & Graf, J. Analysis, optimization and verification of Illumina-generated 16S rRNA gene amplicon surveys. PLoS One 9, e94249 (2014).
10. Subramanian, S. et al. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature 510, 417-421 (2014).
11. Parnham, M. J. et al. Azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacol. Ther. 143, 225-245 (2014).
12. Kanoh, S. & Rubin, B. K. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin. Microbiol. Rev. 23, 590-615 (2010).
13. Lode, H., Borner, K., Koeppe, P. & Schaberg, T. Azithromycin-review of key chemical, pharmacokinetic and microbiological features. J. Antimicrob. Chemother. 37 Suppl C, 1-8 (1996).
14. Gordon, E. M. & Blumer, J. L. Rationale for single and high dose treatment regimens with azithromycin. Pediatr. Infect. Dis. J. 23, S102-107 (2004).
15. Rogawski, E. T. et al. Antibiotic treatment of diarrhoea is associated with decreased time to the next diarrhoea episode among young children in Vellore, India. Int. J. Epidemiol. 44, 978-987 (2015).
16. Abeles, S. R. et al. Microbial diversity in individuals and their household contacts following typical antibiotic courses. Microbiome 4, 39 (2016).
17. Schneeberger, M. et al. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci. Rep. 5, 16643 (2015).
18. Png, C. W. et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 105, 2420-2428 (2010).
19. Dubourg, G. et al. High-level colonisation of the human gut by Verrucomicrobia following broad-spectrum antibiotic treatment. Int. J. Antimicrob. Agents 41, 149-155 (2013).
20. Pehrsson, E. C. et al. Interconnected microbiomes and resistomes in low-income human habitats. Nature 533, 212-216 (2016).
21. D'Amore, R. et al. A comprehensive benchmarking study of protocols and sequencing platforms for 16S rRNA community profiling. BMC Genomics 17, 55 (2016).
22. Caporaso, J. G. et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl Acad. Sci. U. S. A. 108 Suppl 1, 4516-4522 (2011).
23. Jernberg, C., Lofmark, S., Edlund, C. & Jansson, J. K. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 156, 3216-3223 (2010).
24. Sjolund, M., Wreiber, K., Andersson, D. I., Blaser, M. J. & Engstrand, L. Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori. Ann. Intern. Med. 139, 483-487 (2003).
25. Cox, L. M. et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158, 705-721 (2014).
26. Magoc, T. & Salzberg, S. L. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957-2963 (2011).
27. Bokulich, N. A. et al. Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat. Methods 10, 57-59 (2013).
28. Lozupone, C. & Knight, R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 71, 8228-8235 (2005).
29. Oksanen, J. et al. vegan: community ecology package. R package version 2.4-1 (2016).
30. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B 57, 289-300 (1995).
31. Letunic, I. & Bork, P. Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics 23, 127-128 (2007).
32. Breiman, L. & Cutler, A. Random forests. https://www.stat.berkeley.edu/~breiman/RandomForests/cc-home.htm [Accessed 28 April 2016].
33. Strimmer, K. crossval: generic functions for cross validation. R package version 1.0.3 (2015).